Nakashima Naoya, Sueta Daisuke, Kanemaru Yusuke, Takashio Seiji, Yamamoto Eiichiro, Hanatani Shinsuke, Kanazawa Hisanori, Izumiya Yasuhiro, Kojima Sunao, Kaikita Koichi, Hokimoto Seiji, Tsujita Kenichi
Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University, 1-1-1, Honjo, Chuo-ku, Kumamoto 860-8556 Japan.
Thromb J. 2017 Feb 1;15:4. doi: 10.1186/s12959-017-0128-2. eCollection 2017.
Although vein stenting is popular for treatment for venous thromboembolism due to mechanical compression, some cases are forced to avoid inserting align agents because of immunodeficiency.
An 82-year-old man with left extremity redness and swelling presented to a hospital for a medical evaluation. The patient was immunodeficient because of the adverse effects of his treatment for Castleman's disease. A contrast-enhanced computed tomography scan revealed a venous thromboembolism in inferior vena cava and the left lower extremity. Magnetic resonance venography showed that the iliac artery was compressing the iliac vein. We were reluctant to place a stent in the iliac vein has because of the patient's immunodeficient status. Three months of treatment using single-dose edoxaban (30 mg daily) resulted in complete resolution of the thrombus. This is the first report demonstrating that single-dose edoxaban without acute-phase parenteral anticoagulation is effective in the treatment of iliac vein compression.
A single-dose direct oral anti-coagulant without acute-phase parenteral anticoagulation is effective for mechanical compression.